Daniel P. Alford MD, MPH

Professor, General Internal Medicine

Associate Dean, Continuing Medical Education

801 Massachusetts Ave | (617) 414-7399
Daniel Alford
Sections

General Internal Medicine

Centers

Clinical Addiction Research and Education Unit

Biography

Daniel P. Alford, MD, MPH is Professor of Medicine and Associate Dean of Continuing Medical Education at Boston University School of Medicine (BUSM). He is on staff in the Section of General Internal Medicine and Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center. He is the Director of the BUSM Safer/Competent Opioid Prescribing Education (SCOPE of Pain) program which has trained over 240,000 healthcare providers nationally. He is past-president of the Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA). He has been recognized as a “Champion of Change” by the White House and has received the American Medical Association’s “Award for Health Education”, the American Society of Addiction Medicine “Educator of the Year Award”, the American College of Physicians “Award for Distinguished Contributions to Behavioral Medicine” and the AMERSA “McGovern Award for Excellence in Medical Education”. His clinical, educational and research interests focus on managing opioid use disorders and safer and more competent opioid prescribing for managing pain.

Education

Medicine-Internal, MD, Boston University, 1992

Public Health, MPH, Boston University, 1986

BA, Connecticut College, 1981

BA, Marietta College, 1979

Publications

Published on 8/17/2021

Larochelle MR, Cruz R, Kosakowski S, Gourlay DL, Alford DP, Xuan Z, Krebs EE, Yan S, Lasser KE, Samet JH, Liebschutz JM. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain? J Gen Intern Med. 2021 Aug 17. PMID: 34405344.

Published on 1/25/2021

Roseen EJ, Kasali BA, Corcoran K, Masselli K, Laird L, Saper RB, Alford DP, Cohen E, Lisi A, Atlas SJ, Bean JF, Evans R, Bussières A. Doctors of chiropractic working with or within integrated healthcare delivery systems: a scoping review protocol. BMJ Open. 2021 01 25; 11(1):e043754. PMID: 33495261.

Published on 1/8/2021

Laks J, Alford DP, Patel K, Jones M, Armstrong E, Waite K, Henault L, Paasche-Orlow MK. A National Survey on Patient Provider Agreements When Prescribing Opioids for Chronic Pain. J Gen Intern Med. 2021 03; 36(3):600-605. PMID: 33420560.

Published on 10/4/2020

Winhusen T, Walley A, Fanucchi LC, Hunt T, Lyons M, Lofwall M, Brown JL, Freeman PR, Nunes E, Beers D, Saitz R, Stambaugh L, Oga EA, Herron N, Baker T, Cook CD, Roberts MF, Alford DP, Starrels JL, Chandler RK. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study. Drug Alcohol Depend. 2020 12 01; 217:108325. PMID: 33091842.

Published on 4/25/2020

Bertholet N, Meli S, Palfai TP, Cheng DM, Alford DP, Bernstein J, Samet JH, Lloyd-Travaglini C, Saitz R. Screening and brief intervention for lower-risk drug use in primary care: A pilot randomized trial. Drug Alcohol Depend. 2020 Apr 25; 213:108001. PMID: 32563116.

Published on 1/1/2020

John RS, Salas-Wright CP, Amodeo M, Chassler D, Alford DP. Faculty education in addiction training (FEAT): Evaluating an online training program for multidisciplinary health professions educators. Subst Abus. 2020; 41(3):292-296. PMID: 32697174.

Published on 11/27/2019

Levy S, Seale JP, Alford DP. Medicine, with a focus on physicians: Addressing substance use in the 21st century. Subst Abus. 2019; 40(4):396-404. PMID: 31774388.

Published on 7/30/2019

Kertesz SG, Satel SL, DeMicco J, Dart RC, Alford DP. Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention. Subst Abus. 2019; 40(4):466-468. PMID: 31361588.

Published on 5/17/2019

Kertesz SG, Satel SL, DeMicco J, Dart RC, Alford DP. Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention. Subst Abus. 2019; 40(1):4-6. PMID: 31100051.

Published on 5/1/2019

Alford DP, Lazure P, Murray S, Hardesty I, Krause JR, White JL. National Trends in Prescription Opioid Risk Mitigation Practices: Implications for Prescriber Education. Pain Med. 2019 05 01; 20(5):907-915. PMID: 30789651.

View full list of 84 publications.